Based on the above analysis, we speculated that the HPV‐ HNSCC group with high PLEK2 expression might be considered to have a worse outcome, which is in line with many previous studies that have demonstrated that HPV+HNSCC was related to better survival prognosis.32, 33. The gene discussed is PLEK2; the disease is head and neck squamous cell carcinoma.